| Literature DB >> 4576682 |
Abstract
The ability of intravenously injected Candida albicans to cause thrombocytopenia and clotting disorders was tested. Mice injected in this manner showed a decrease in circulating platelets and a shortening of clotting time within hours after challenge. Treatment with heparin changed the death distribution pattern, but did not increase overall long-term survival. A cell-free sonic extract prepared from viable C. albicans cells was shown to cause aggregation of platelets in vitro, and injection of the cell-free extract into mice caused a decrease in circulating platelets similar to that observed when viable organisms were injected.Entities:
Mesh:
Substances:
Year: 1973 PMID: 4576682 PMCID: PMC422701 DOI: 10.1128/iai.7.3.468-472.1973
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441